STAT

SEPTEMBER 26, 2023

The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous

Vaccines 363

Vaccines 363

PharmaVoice

SEPTEMBER 26, 2023

From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.

264

264

STAT

SEPTEMBER 26, 2023

Jobs in health care are known to be challenging for workers’ mental health. But the mental health toll can be especially burdensome for registered nurses, health technicians, and health care support workers, who are at a higher risk of suicide compared to the general population, according to a study published on Tuesday in the Journal of the American Medical Association that looked at a nationally representative cohort of about 1.84 million employed people (both within the health care fie

341

341

PharmaVoice

SEPTEMBER 26, 2023

The Flagship-backed biotech believes the secret to more precise drug delivery lies in the nanoparticles of plants and fungi.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 26, 2023

Patriarchy isn’t a word that Ophira Ginsburg expected to be at the center of her work as a cancer researcher but, like an infection, it was invading her everyday work as a medical oncologist. There were times when she saw people treat women’s lives and health with cruel indifference. There were times when she saw women who struggled to access care because of violence or social obligations or stigma.

336

336

The Pharmacist

SEPTEMBER 26, 2023

Community pharmacies and other vaccination providers are being urged to make sure pregnant women know they are eligible for booster vaccinations this autumn amid concerns over the latest Covid variant. A total of 1.16 million Covid jabs were delivered in total in the first week of the programme. Some 2.8 million flu jabs were also […] The post Encourage pregnant women to take up Covid jab offer, NHSE asks appeared first on The Pharmacist.

Community Pharmacies 111

Community Pharmacies Vaccines 111

Pharma Times

SEPTEMBER 26, 2023

Agreement will provide timely boost to pandemic preparedness against influenza - News - PharmaTimes

Vaccines 140

Vaccines 140

STAT

SEPTEMBER 26, 2023

Extending patent protection doesn’t just stretch a drug’s profits — in some cases, doing so can lead to its most significant revenue period, according to a recent analysis published by the Initiative for Medicines, Access & Knowledge, or I-MAK, a nonprofit advocating for drug pricing reforms. The organization looked at four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — that had biosimilars launched between 2019 and 2023.

Drug Pricing 318

Drug Pricing Biosimilars Drug Development 318

BioPharma Dive

SEPTEMBER 26, 2023

Once valued at more than $7 billion, the liver drug company couldn’t secure a long-sought FDA approval in NASH and last month said it would abandon that research.

109

109

STAT

SEPTEMBER 26, 2023

The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid. “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital.

Hospitals 305

Hospitals 305

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

SEPTEMBER 26, 2023

EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate - News - PharmaTimes

132

132

STAT

SEPTEMBER 26, 2023

Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’ Immunovant showed the treatment could reduce the levels of a key immune marker in the blood, a promising signal. The results are only from a Phase 1 trial, but were anticipated because they were the first-in-human outcomes being reported for the antibody drug, IMVT-1402.

Immunity 295

Immunity Immunization Drug Development 295

BioPharma Dive

SEPTEMBER 26, 2023

Much anticipated clinical trial data for Immunovant’s experimental FcRn inhibitor could catalyze business development decisions for its parent, Roivant Sciences.

105

105

STAT

SEPTEMBER 26, 2023

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S.,  37 biosimilars  have come to market offering the potential to increase patient choice and cost savings.

Biosimilars 271

Biosimilars 271

Express Pharma

SEPTEMBER 26, 2023

The Mehta family, the promoter of the Lilavati Hospital, is establishing a chain of Lilavati Pharmacy stores across the country. The Lilavati Pharmacy project is being driven by Prashant Mehta, the promoter and MD. The Lilavati Pharmacy chain will also commence a wellness programme for community members. Customers will be able to consult a doctor at the pharmacy itself and seek an appropriate line of treatment.

Hospitals 100

Hospitals 100

STAT

SEPTEMBER 26, 2023

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion. Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept , in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price.

250

250

Express Pharma

SEPTEMBER 26, 2023

Queen’s University Belfast conducted a comprehensive study of the initial wave of precision oncology medicines. This was conducted in collaboration with a team of precision healthcare economists and researchers from Salutem Insights, Diaceutics PLC and King’s College London. The study examined the economic impact of precision oncology medicines compared to traditional oncology medicines.

99

99

STAT

SEPTEMBER 26, 2023

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial. The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s ex

Drug Development 242

Drug Development 242

Express Pharma

SEPTEMBER 26, 2023

Indian Institute of Technology Mandi researchers, led by Dr Amit Prasad, Associate Professor, School of Biosciences and Bioengineering, has made strides in the development of vaccines against the pork tapeworm (T. solium). This tapeworm is responsible for both intestinal infections and the more severe brain infection that leads to seizures. Their research, conducted in collaboration with scientists from Dayanand Medical College and Hospital in Punjab and the CSIR-Institute for Himalayan Bioresou

Vaccines 99

Vaccines Immunity Immunization Hospitals 99

STAT

SEPTEMBER 26, 2023

If you’re surprised Elevance Health is having trouble buying a not-for-profit Blues plan, you haven’t been paying attention. The insurance behemoth hasn’t pulled off such a deal in almost 20 years. Elevance’s announcement that it’s pausing its $2.5 billion bid to buy Blue Cross and Blue Shield of Louisiana follows strong pushback amid concerns about higher prices, fairness to members, and uncertainty over what would happen with the billions in proceeds.

Hospitals 213

Hospitals 213

Pharmaceutical Business Review

SEPTEMBER 26, 2023

ALTUVIIIO, also known as efanesoctocog alfa, is an antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein used for perioperative management of bleeding, controlling bleeding episodes, and routine prophylaxis. The recommended dosage of ALTUVIIIO for all patients, and when used under different clinical scenarios is 50 IU/kg. The company claimed that ALTUVIIIO is the first and only hemophilia A treatment that can deliver normal to near-normal factor activity levels (over 40%) for most of t

Dosage 98

Dosage 98

STAT

SEPTEMBER 26, 2023

Hello, everyone, and nice to see you again after we engaged in an extended respite. We took the opportunity to recharge and reflect, but now, of course, have returned to the usual routine of deadlines and calls and the like. So time to fire up the coffee kettle and quaff a few cups of stimulation. We are starting today with glazed doughnut, since one can never be too sweet, yes?

Documentation 204

Documentation 204

European Pharmaceutical Review

SEPTEMBER 26, 2023

Pharmaceutical companies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. These database transfer activities must follow industry standards and pharmacovigilance regulation, which has become increasingly stringent over the last decade. The concept of good pharmacovigilance practice (GVP) has been implemented in multiple regions across the globe to ensure these migrations are validated and data integrity i

Documentation 95

Documentation Data Entry Pharmaceutical Companies Pharmaceutical Companies 95

Express Pharma

SEPTEMBER 26, 2023

Dr Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers and Minister of Health & Family Welfare, Government of India launched of National Policy on Research and Development and Innovation in pharma-medtech sector in India and Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP). Dr V K Paul, Member, NITI Aayog, S Aparna, Secretary (Pharma), Ministry of Chemicals and Fertilizers and Dr Rajiv Bahl, Director General, ICMR were also present at the event.

Biosimilars 90

Biosimilars 90

European Pharmaceutical Review

SEPTEMBER 26, 2023

Resminostat (Kinselby) has been clinically proven to postpone disease progression, new data from one of the largest clinical trials in cutaneous T-cell lymphoma (CTCL) to date has revealed. The treatment is an oral small molecule class I, IIb and IV histone deacetylase (HDAC) inhibitor. Data from the RESMAIN resminostat study Findings from the RESMAIN study of the maintenance therapy could significantly change clinical practice in advanced CTCL, according to the company.

Labelling 90

Labelling Drug Development 90

The Pharmacist

SEPTEMBER 26, 2023

Pharmacies should be part of the primary care offer and do more for their communities, the shadow minister for primary care and public health, Preet Kaur Gill, has said. The comments were made in a video filmed during a visit to an independent community pharmacy in Staffordshire last week. Ms Gill, who is the Labour […] The post Pharmacies must be ‘part of the primary care offer’, says Labour appeared first on The Pharmacist.

Community Pharmacies 96

Community Pharmacies 96

PharmExec

SEPTEMBER 26, 2023

Accenture’s global life sciences technology lead discusses how the life sciences industry has embraced artificial intelligence.

105

105

The Pharmacist

SEPTEMBER 26, 2023

The drug reimbursement system in England is in ‘significant peril’, Community Pharmacy England’s director of pharmacy funding Mike Dent has said. This comes as the £100m in additional margin allowance that was granted back to the sector last April has been phased out. In the new drug tariff, the government has also made a downward […] The post Medicine reimbursement system ‘in significant peril’ as £100m write-off ends appeared first on The Pharmacist.

Community Pharmacies 91

Community Pharmacies 91

Outsourcing Pharma

SEPTEMBER 26, 2023

BioPharma Reporter and Outsourcing Pharma is keeping you in the know with our most recent round-up of important appointments in the pharma industry - including Veranova, Matica Bio and Aldevron.

98

98

pharmaphorum

SEPTEMBER 26, 2023

Post-pandemic reality hits digital health hard Mike.

122

122

Outsourcing Pharma

SEPTEMBER 26, 2023

A rare and incurable blood cancer, associated with an overproduction of blood cells, that can lead to stroke or heart attack, will soon have access to a small molecule Novartis treatment for the condition.

98

98

Pharmafile

SEPTEMBER 26, 2023

Regeneron Pharmaceuticals and Sanofi have announced that the US Food and Drug Administration (FDA) has accepted their supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for the treatment of children between one and 11 years old with eosinophilic esophagitis (EoE). The target action date for an FDA decision is 31 January 2024.

63

63

Outsourcing Pharma

SEPTEMBER 26, 2023

A new approach to discovering targets for Alzheimerâs and other neurodegenerative diseases has been presented by Insilico Medicine with the University of Cambridge, UK.

98

98

World Pharma News

SEPTEMBER 26, 2023

Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited available treatment options, underscoring the pressing need to better understand why people get this disease. In a new study, Boston University Chobanian & Avedisian School of Medicine researchers have identified that abnormal interactions between different cell types, particularly platelets and lung immune cells, promote l

Immunity 65

Immunity Immunization 65

Outsourcing Pharma

SEPTEMBER 26, 2023

Drug discovery will benefit from a virtual artificial intelligence (AI) expert thanks to Opportunity Pharma and OpenEye, Cadence Molecular Sciences joining forces.

97

97